# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-041808
Filing Date
2024-05-10
Accepted
2024-05-10 17:00:35
Documents
108
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ANNUAL REPORT | ea0203872-20f_tiziana.htm iXBRL | 20-F | 2182961
2 | DESCRIPTION OF SECURITIES | ea020387201ex2-1_tiziana.htm | EX-2.1 | 4872
3 | CERTIFICATION | ea020387201ex12-1_tiziana.htm | EX-12.1 | 9529
4 | CERTIFICATION | ea020387201ex12-2_tiziana.htm | EX-12.2 | 9507
5 | CERTIFICATION | ea020387201ex13-1_tiziana.htm | EX-13.1 | 3818
6 | CERTIFICATION | ea020387201ex13-2_tiziana.htm | EX-13.2 | 3802
7 | CONSENT OF MAZARS LLP | ea020387201ex15-1_tiziana.htm | EX-15.1 | 2114
8 | CONSENT OF PKF LITTLEJOHN | ea020387201ex15-2_tiziana.htm | EX-15.2 | 2512
9 | CLAWBACK POLICY | ea020387201ex97_tiziana.htm | EX-97. | 48258
10 | GRAPHIC | image_001.jpg | GRAPHIC | 22549
11 | GRAPHIC | image_002.jpg | GRAPHIC | 30561
12 | GRAPHIC | image_003.jpg | GRAPHIC | 23286
13 | GRAPHIC | ex15-2_001.jpg | GRAPHIC | 7716
| Complete submission text file | 0001213900-24-041808.txt |  | 7834915

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
14 | XBRL SCHEMA FILE | tlsa-20231231.xsd | EX-101.SCH | 132349
15 | XBRL CALCULATION FILE | tlsa-20231231_cal.xml | EX-101.CAL | 38709
16 | XBRL DEFINITION FILE | tlsa-20231231_def.xml | EX-101.DEF | 302628
17 | XBRL LABEL FILE | tlsa-20231231_lab.xml | EX-101.LAB | 683943
18 | XBRL PRESENTATION FILE | tlsa-20231231_pre.xml | EX-101.PRE | 327842
112 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0203872-20f_tiziana_htm.xml | XML | 871925

Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38723 | Film No.: 24935844
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)